Apeloa Pharmaceutical Co Ltd Financial Flexibility Index
Apeloa Pharmaceutical Co Ltd financial flexibility index. Apeloa Pharmaceutical Co Ltd (000739) has a Financial Flexibility Index of 0.10x as of December 2025. Free cash flow of CN¥612.91 Million (operating CF CN¥446.18 Million minus capex CN¥166.73 Million) represents 0% of total liabilities (CN¥5.97 Billion). See Apeloa Pharmaceutical Co Ltd (000739) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Apeloa Pharmaceutical Co Ltd (1998–2025)
Financial flexibility index of Apeloa Pharmaceutical Co Ltd from 1998 to 2025. Historical Financial Flexibility Index trend for Apeloa Pharmaceutical Co Ltd across 28 annual periods. Check Apeloa Pharmaceutical Co Ltd earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
Apeloa Pharmaceutical Co Ltd Financial Flexibility Index by Year (1998–2025)
Apeloa Pharmaceutical Co Ltd financial flexibility index by year from 1998 to 2025. Year-by-year free cash flow to debt coverage for Apeloa Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see cash flow conversion of Apeloa Pharmaceutical Co Ltd.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.27x | CN¥1.62 Billion | CN¥1.23 Billion | CN¥5.97 Billion | ▼ -3.0% |
| 2024 | 0.28x | CN¥1.67 Billion | CN¥1.21 Billion | CN¥5.98 Billion | ▲ +9.8% |
| 2023 | 0.25x | CN¥1.66 Billion | CN¥1.03 Billion | CN¥6.54 Billion | ▼ -9.9% |
| 2022 | 0.28x | CN¥1.84 Billion | CN¥1.33 Billion | CN¥6.50 Billion | ▼ -14.4% |
| 2021 | 0.33x | CN¥1.31 Billion | CN¥611.75 Million | CN¥3.98 Billion | ▼ -25.7% |
| 2020 | 0.44x | CN¥1.38 Billion | CN¥1.06 Billion | CN¥3.10 Billion | ▼ -12.2% |
| 2019 | 0.51x | CN¥1.39 Billion | CN¥1.36 Billion | CN¥2.75 Billion | ▲ +33.0% |
| 2018 | 0.38x | CN¥914.32 Million | CN¥832.69 Million | CN¥2.41 Billion | ▲ +168.9% |
| 2017 | 0.14x | CN¥373.22 Million | CN¥209.80 Million | CN¥2.64 Billion | ▼ -17.1% |
| 2016 | 0.17x | CN¥511.77 Million | CN¥180.42 Million | CN¥3.00 Billion | ▼ -43.2% |
| 2015 | 0.30x | CN¥893.23 Million | CN¥441.16 Million | CN¥2.98 Billion | ▼ -37.7% |
| 2014 | 0.48x | CN¥1.33 Billion | CN¥786.64 Million | CN¥2.76 Billion | ▲ +94.2% |
| 2013 | 0.25x | CN¥695.45 Million | CN¥190.45 Million | CN¥2.80 Billion | ▲ +0.6% |
| 2012 | 0.25x | CN¥675.49 Million | CN¥335.90 Million | CN¥2.74 Billion | ▼ -14.9% |
| 2011 | 0.29x | CN¥693.83 Million | CN¥404.62 Million | CN¥2.40 Billion | ▲ +15.0% |
| 2010 | 0.25x | CN¥260.85 Million | CN¥121.05 Million | CN¥1.04 Billion | ▼ -20.4% |
| 2009 | 0.32x | CN¥301.95 Million | CN¥208.30 Million | CN¥954.91 Million | ▼ -30.6% |
| 2008 | 0.46x | CN¥443.61 Million | CN¥94.57 Million | CN¥973.00 Million | ▲ +35.9% |
| 2007 | 0.34x | CN¥289.90 Million | CN¥174.20 Million | CN¥864.02 Million | ▲ +30.4% |
| 2006 | 0.26x | CN¥213.27 Million | CN¥159.43 Million | CN¥828.68 Million | ▼ -9.8% |
| 2005 | 0.29x | CN¥209.05 Million | CN¥87.40 Million | CN¥732.94 Million | ▲ +33.7% |
| 2004 | 0.21x | CN¥158.61 Million | CN¥47.54 Million | CN¥743.40 Million | ▼ -41.1% |
| 2003 | 0.36x | CN¥193.45 Million | CN¥105.36 Million | CN¥534.24 Million | ▲ +186.2% |
| 2002 | 0.13x | CN¥50.05 Million | CN¥2.81 Million | CN¥395.59 Million | ▲ +8937.8% |
| 2001 | 0.00x | CN¥458.70K | CN¥-569.79K | CN¥327.67 Million | ▼ -97.6% |
| 2000 | 0.06x | CN¥10.30 Million | CN¥7.08 Million | CN¥177.79 Million | ▲ +196.7% |
| 1999 | -0.06x | CN¥-12.72 Million | CN¥-20.52 Million | CN¥212.40 Million | ▼ -129.2% |
| 1998 | 0.20x | CN¥46.53 Million | CN¥30.10 Million | CN¥227.17 Million | — |